These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
92 related items for PubMed ID: 2483253
1. [Chemosensitivity of human head and neck tumors detected by human tumor clonogenic assay]. Suzuki K, Fujii M, Ishii Y, Mochizuki F, Suzuki K, Yamagata M, Suzuki H, Moriya Y, Abiko Y, Sakabe T. Nichidai Koko Kagaku; 1989 Jun; 15(2):153-6. PubMed ID: 2483253 [Abstract] [Full Text] [Related]
2. [Chemotherapy in the multi-disciplinary treatment of head and neck tumors: evaluation of a chemosensitivity test]. Saito H. Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1744-52. PubMed ID: 3729480 [Abstract] [Full Text] [Related]
3. [Radio- and radio-chemosensitivity of human head and neck cancer cell line detected by human tumor clonogenic assay]. Suzuki K, Fujii M, Ishii Y, Mochizuki F, Suzuki K, Yamagata M, Suzuki H, Moriya Y, Abiko Y, Sakabe T. Nichidai Koko Kagaku; 1989 Jun; 15(2):157-65. PubMed ID: 2483254 [Abstract] [Full Text] [Related]
4. [Chemosensitivity testing of anticancer agents in head and neck tumors. I: Comparison between head and neck squamous cell cancers and thyroid cancers]. Nakashima T, Tomita K, Kuratomi Y, Maehara Y, Kohnoe S. Gan To Kagaku Ryoho; 1990 Jan; 17(1):79-84. PubMed ID: 2297240 [Abstract] [Full Text] [Related]
5. [Head and neck cancer]. Inuyama Y, Fukuda S, Fujii M, Tanaka K, Kawaura M, Kawasaki K, Kohno N. Gan To Kagaku Ryoho; 1996 Aug; 23(9):1136-42. PubMed ID: 8751800 [Abstract] [Full Text] [Related]
6. [Chemotherapy of ovarian cancer based on in vitro (HTCA) and in vivo (nude mice) chemosensitivity testing]. Sagawa T, Yamashita K, Kawamura M, Shimizu T, Haga H, Yorozu Y, Kasamo M, Fujita M. Nihon Sanka Fujinka Gakkai Zasshi; 1985 Jul; 37(7):1197-204. PubMed ID: 2411831 [Abstract] [Full Text] [Related]
7. Chemosensitivity testing of xenografted squamous cell carcinomas of the head and neck region. Elprana D, Kuijpers W, Wessels JM, Wagener DJ, van den Broek P. Anticancer Res; 1992 Jul; 12(6B):2229-39. PubMed ID: 1284201 [Abstract] [Full Text] [Related]
8. Polymer chemotherapy for head and neck cancer. Shikani AH, Domb AJ. Laryngoscope; 2000 Jun; 110(6):907-17. PubMed ID: 10852503 [Abstract] [Full Text] [Related]
9. Enhanced antitumor efficacy of nedaplatin with 5-fluorouracil against human squamous carcinoma xenografts. Takeda Y, Kasai H, Uchida N, Yoshida H, Maekawa R, Sugita K, Yoshioka T. Anticancer Res; 1999 Jun; 19(5B):4059-64. PubMed ID: 10628354 [Abstract] [Full Text] [Related]
10. In vitro chemosensitivity testing of squamous cell carcinoma of the head and neck. A preliminary report. Elprana D, Schwachöfer J, Kuijpers W, van den Broek P, Wagener DJ. Acta Otolaryngol; 1987 Jun; 103(5-6):529-36. PubMed ID: 2441566 [Abstract] [Full Text] [Related]
11. [Low-dose CDDP and 5-FU for head and neck cancer patients]. Fujii M, Kanke M, Tomita T. Gan To Kagaku Ryoho; 1999 Oct; 26(11):1542-7. PubMed ID: 10553410 [Abstract] [Full Text] [Related]
12. [Combination chemotherapy with 5-FU and CDDP or CDDP analog for head and neck cancer]. Fujii M, Ohno Y, Tokumaru Y, Imanishi Y, Kanke M. Gan To Kagaku Ryoho; 1996 Nov; 23(13):1740-6. PubMed ID: 8937483 [Abstract] [Full Text] [Related]
13. Apoptosis induction and enhancement of cytotoxicity of anticancer drugs by celecoxib, a selective cyclooxygenase-2 inhibitor, in human head and neck carcinoma cell lines. Hashitani S, Urade M, Nishimura N, Maeda T, Takaoka K, Noguchi K, Sakurai K. Int J Oncol; 2003 Sep; 23(3):665-72. PubMed ID: 12888902 [Abstract] [Full Text] [Related]
14. [Treatment of epidermoid head and neck cancer with cisplatinum/bleomycin vs methotrexate/vindesine]. Schröder M, von Heyden HW, Beyer JH, Klee M. Laryngol Rhinol Otol (Stuttg); 1981 Jun; 60(6):331-3. PubMed ID: 6167831 [Abstract] [Full Text] [Related]
15. Pilot study of intraoperative chemotherapy with cisplatin and 5-fluorouracil in patients with advanced squamous cell carcinoma of the head and neck. Tulunay OE, Enamorado II, Kucuk O, Heilbrun LK, Otero JE, Korkmaz H, Blumberg R, Jacobs JR. Head Neck; 2007 Mar; 29(3):267-71. PubMed ID: 17163471 [Abstract] [Full Text] [Related]
16. Correlations between thymidylate synthase expression and chemosensitivity to 5-fluorouracil, cell proliferation and clinical outcome in head and neck squamous cell carcinoma. Yasumatsu R, Nakashima T, Uryu H, Ayada T, Wakasaki T, Kogo R, Masuda M, Fukushima M, Komune S. Chemotherapy; 2009 Mar; 55(1):36-41. PubMed ID: 19023200 [Abstract] [Full Text] [Related]
17. Salvage chemotherapy with PEM and long-CF regimen in CDDP refractory advanced head and neck cancer. Kohno N, Ichikawa G, Shirasaka T, Inuyama Y, Kawaida M, Ohnuma T. Gan To Kagaku Ryoho; 1995 Aug; 22 Suppl 3():209-14. PubMed ID: 7661582 [Abstract] [Full Text] [Related]
18. Cisplatin, fluorouracil, and L-leucovorin induction chemotherapy for locally advanced head and neck cancer: the M.D. Anderson Cancer Center experience. Papadimitrakopoulou VA, Dimery IW, Lee JJ, Perez C, Hong WK, Lippman SM. Cancer J Sci Am; 1997 Aug; 3(2):92-9. PubMed ID: 9099459 [Abstract] [Full Text] [Related]
19. [Experiences using combination chemotherapy with cis-platinum, bleomycin and methotrexate in the management of advanced squamous cell carcinomas of the head and neck (author's transl)]. Jahnke V. HNO; 1980 Dec; 28(12):405-8. PubMed ID: 6161913 [Abstract] [Full Text] [Related]
20. Detection of hypoxia by measurement of DNA damage and repair in human lymphocytes (comet assay): a predictive variable for tumor response during chemotherapy in patients with head and neck squamous cell carcinoma. Romanet T, Ré JL, De Méo M, Serre-Debeauvlais F, Lavieille JP, Reyt E, Riva C. In Vivo; 1999 Dec; 13(4):343-8. PubMed ID: 10586376 [Abstract] [Full Text] [Related] Page: [Next] [New Search]